Drug Database
Back to search

Norway· NO-ID_4E98AA07-CDBF-421D-A07B-642D873053D4

Glib-ratiopharm S

A glibenclamide product containing glibenclamide, registered in Norway by Ratiopharm. The same ATC class is registered in 17 of our 19 countries.

ATC A10BB01

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedGlib-ratiopharm SATCA10BB01REGISTER NO.NO-ID_4E98AA07-CDBF-4…PACKS LISTED3CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about glibenclamideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Glibenclamide is registered in 17 of 19 countries.

Countries holding a registration under ATC A10BB01 (glibenclamide), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 10 of them publish a price we can compare per daily dose
Search glibenclamide products by name

Glibenclamide · ATC A10BB01

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of glibenclamide costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.19 in France to $0.82 in Switzerland — a ×4.4 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Glibenclamide · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.82
  • IT Italy$0.22
  • FR France$0.19
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Glibenclamide
Manufacturer
Ratiopharm
Country
Norway (NO)
ATC code
A10BB01
ATC class
Glibenclamide
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

  • no_merkevare_id
    ID_4E98AA07-CDBF-421D-A07B-642D873053D4
  • no_varenummer
    286133
    30
  • gtin
    4150084948005

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

767 interactions on record for glibenclamide.

Graded by severity as the source publishes them — 21 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check glibenclamide against other medicinesHow interaction checks work

Glibenclamide · interactions on record

767 records

  • 21 severe
  • 472 moderate
  • 52 minor
  • 222 info

Most severe, free to view

  • MiconazoleA07AC01severe
  • BosentanC02KX01severe
  • Magnesium carbonateA02AA01moderate
  • Magnesium oxideA02AA02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Glibenclamide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glibenclamide products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Cyprus · Glibesyn, Glitisol
  • Germany · Glib-Ratiopharm S, Glibenclamid Abz
  • Spain · Glucolón
  • France · Daonil, Glibenclamide Arrow
  • United Kingdom (Northern Ireland) · Glibenclamide Activase Pharmaceuticals, Glibenclamide Ennogen Ip
  • Greece · Asugrin, Deroctyl
  • Iceland · Amglidia
  • Italy · Gliben, Gliboral
  • Liechtenstein · Amglidia
  • Malta · Glitisol
  • Portugal · Glibenclamida Generis
  • Romania · Glibenclamidă Arena

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/03e9e7fa-2148-4bcf-9604-ad44f32983da
GET /v1/drugs/03e9e7fa-2148-4bcf-9604-ad44f32983da?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett",
  "source": "fest",
  "status": "A",
  "atc_name": "Glibenklamid",
  "merkevare_id": "ID_4E98AA07-CDBF-421D-A07B-642D873053D4",
  "name_form_strength": "Glib-ratiopharm S tab 3,5 mg",
  "prescription_group": "C"
}
API referenceMCP serverPlans

See everything about glibenclamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console